Galectin-9 in physiological and pathological conditions

被引:163
|
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [1] Galectin-9 in physiological and pathological conditions
    Mitsuomi Hirashima
    Yumiko Kashio
    Nozomu Nishi
    Akira Yamauchi
    Tada-Atsu Imaizumi
    Toshiro Kageshita
    Naoki Saita
    Takanori Nakamura
    Glycoconjugate Journal, 2002, 19 : 593 - 600
  • [2] Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
    Kong, Fei
    Jin, Meishan
    Cao, Donghui
    Jia, Zhifang
    Liu, Yawen
    Jiang, Jing
    PEERJ, 2020, 8
  • [3] Galectin-9 in Gastroenterological Cancer
    Morishita, Asahiro
    Oura, Kyoko
    Tadokoro, Tomoko
    Shi, Tingting
    Fujita, Koji
    Tani, Joji
    Atsukawa, Masanori
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [4] Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
    Liu, Yidong
    Liu, Zheng
    Fu, Qiang
    Wang, Zewei
    Fu, Hangcheng
    Liu, Weisi
    Wang, Yiwei
    Xu, Jiejie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (06) : 349 - 355
  • [5] Cancer Therapy Due to Apoptosis: Galectin-9
    Fujita, Koji
    Iwama, Hisakazu
    Oura, Kyoko
    Tadokoro, Tomoko
    Samukawa, Eri
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Morishita, Asahiro
    Himoto, Takashi
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [6] Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
    Zhang, Zhao-Yang
    Dong, Jia-Hong
    Chen, Yong-Wei
    Wang, Xian-Qiang
    Li, Chong-Hui
    Wang, Jian
    Wang, Guo-Qiang
    Li, Hai-Lin
    Wang, Xue-Dong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2503 - 2509
  • [7] Galectin-9 suppresses the proliferation of gastric cancer cells in vitro
    Takano, Jitsuko
    Morishita, Asahiro
    Fujihara, Shintaro
    Iwama, Hisakazu
    Kokado, Fuyuko
    Fujikawa, Iceiko
    Fujita, Koji
    Chiyo, Taiga
    Tadokoro, Tomoko
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Miyoshi, Hisaaki
    Yoneyama, Hirohito
    Kobara, Hideki
    Mori, Hirohito
    Niki, Toshihiro
    Hirashinia, Mitsuomi
    Masaki, Tsutomu
    ONCOLOGY REPORTS, 2016, 35 (02) : 851 - 860
  • [8] Galectin-9 ameliorates fulminant liver injury
    Tadokoro, Tomoko
    Morishita, Asahiro
    Sakamoto, Teppei
    Fujihara, Shintaro
    Fujita, Koji
    Mimura, Shima
    Oura, Kyoko
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Iwama, Hisakazu
    Himoto, Takashi
    Niki, Toshiro
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    MOLECULAR MEDICINE REPORTS, 2017, 16 (01) : 36 - 42
  • [9] Galectin-9: An anticancer molecule for gallbladder carcinoma
    Tadokoro, Tomoko
    Morishita, Asahiro
    Fujihara, Shintaro
    Iwama, Hisakazu
    Niki, Toshiro
    Fujita, Koji
    Akashi, Emiko
    Mimura, Shima
    Oura, Kyoko
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Miyoshi, Hisaaki
    Yoneyama, Hirohito
    Himoto, Takashi
    Hirashima, Mitsuomi
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 1165 - 1174
  • [10] Therapeutic potential of Galectin-9 in human disease
    Wiersma, Valerie R.
    de Bruyn, Marco
    Helfrich, Wijnand
    Bremer, Edwin
    MEDICINAL RESEARCH REVIEWS, 2013, 33 : E102 - E126